Structural model of polymeric nanospheres containing indomethacin ethyl ester and in vivo antiedematogenic activity

International Journal of Nanotechnology

Volumn 4, Issue 5, 2007, Pages 454-467

  Pohlmann, Adriana R ^a   Cruz, Letícia ^a   Mezzalira, Graziela ^a   Soares, Leonardo U ^a   Da Silveira, Nádya P ^a   Guterres, Sílvia S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Antiedematogenic activity; Diffusion; Indomethacin ester; Mathematical modelling; Nanospheres; Polymeric nanoparticles; Release; SAXS

Indexed keywords

ESTERS; LIGHT SCATTERING; MATHEMATICAL MODELS; NANOPARTICLES; POLYMERS; SOLUBILITY;

ANTIEDEMATOGENIC ACTIVITY; INDOMETHACIN ESTER; POLYMERIC NANOPARTICLES;

NANOSPHERES;

EID: 34748920704     PISSN: 14757435     EISSN: None     Source Type: Journal    
DOI: 10.1504/IJNT.2007.014744     Document Type: Conference Paper

References (41)

1. Brannon-Peppas, L. (1995) 'Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery', Int. J. Pharm., Vol. 116, pp. 1-9.
2. Montasser, I., Briançon, S., Lieto, J. and Fessi, H. (2000) 'Methods of preparation and mechanisms of formation of polymeric nanoparticles', J. Pharm. Belg., Vol. 55, pp.155-167.
3. Ravi Kumar, M.N.V. (2000) 'Nano and microparticles as controlled drug delivery devices', J. Pharm. Sci, Vol. 3, No. 2, pp.234-258.
4. Soppimath, K.S., Aminabhavi, T.M., Kulkami, A.R. and Rudziski, W.E. (2001) 'Biodegradable polymeric nanoparticles as drug delivery devices', J. Controlled Release, Vol. 70, pp. 1-20.
5. Couvreur, P., Barratt, G., Fattal, E., Legrand, P. and Vauthier, C. (2002) 'Nanocapsule technology: a review', Crit. Rev. Ther. Drug Carrier Syst., Vol. 19, No. 2, pp.99-134.
6. Schaffazick, S.R., Guterres, S.S., Freitas, L.L. and Pohlmann, A.R. (2003) 'Caracterização físico-química e estabilidade de sistemas nanoestruturados para administração de fármacos', Quim. Nova, Vol. 26, No. 5, pp.726-737.
7. Vauthier, C,. Dubernet, C., Fattal, E., Pinto-Alphandary, H. and Couvreur, P. (2003) 'Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications', Adv. Drug Delivery. Rev., Vol. 55, pp.519-548.
8. Pinto-Alphandary, H., Andremont, A. and Couvreur, P. (2000) 'Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications', Int. J. Antimicrob. Agents, Vol. 13, No. 3, pp.155-168.
9. Couvreur, P., Dubernet, C. and Puisieux, F. (1995) 'Controlled drug delivery with nanoparticles: current possibilities and future trends', Eur. J. Pharm. Biopharm., Vol. 41, pp.2-13.
10. Guterres, S.S., Fessi, H., Barratt, G., Devissaguet, J.P. and Puisieux, F. (1995) 'Poly(D,L-lactide) nanocapsules containing diclofenac: I. Formulation and stability study', Int. J. Pharm., Vol. 113, pp.57-63.
11. Guterres, S.S., Muller, CR., Michalowski, C.B., Pohlmann, A.R. and Dalla Costa, T. (2001) 'Gastro-intestinal tolerance following oral administration of spray-dried diclofenac-loaded nanocapsules and nanospheres', STP Pharm. Sci., Vol. 11, No. 3, pp.229-233.
12. Calvo, P., Vila-Jato, J.L. and Alonso, M.J. (1996) 'Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules and nanoemulsions, as ocular drug carrier', J. Pharm. Sci, Vol. 85, No. 5, pp.530-536.
13. Ding, S. (1998) 'Recent developments in ophthalmic drug delivery', Pharm. Sci. Technol. Today, Vol. 1, No. 8, pp.328-335.
14. Jung, T., Kamm, W., Breitenbach, A., Kaiserling, E., Xiao, J.X. and Kissel, T. (2000) 'Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?', Eur. J. Pharm. Biopharm., Vol. 50, pp. 147-160.
15. Vila, A., Sánchez, A., Tobio, M., Calvo, P. and Alonso, M.J. (2002) 'Design of biodegradable particles for protein delivery', J. Controlled Release, Vol. 78, pp.15-24.
16. Cruz, L., Soares, L.U., Dalla Costa, T., Mezzalira, G., Pesce da Silveira, N., Guterres, S.S. and Pohlmann, A.R. (2006) 'Diffusion and mathematical modeling of release profiles from nanocarriers', Int. J. Pharm., Vol. 313, pp.198-205.
17. Washington, C. (1990) 'Drug release from microdisperse systems: a critical review', Int. J. Pharm., Vol. 58,pp.l-12.
18. Polakovic, M., Görner, T., Gref, R. and Dellacherie, E. (1999) 'Lidocaine loaded biodegradable nanospheres II. Modeling of drug release', J. Controlled Release, Vol. 60, pp. 169-177.
19. Rouzes, C., Leonard, M., Durand, A. and Dellacherie, M. (2003) 'Influence of polymeric surfactants on the properties of drug-loaded PLA nanospheres', Colloids. Surf., B: Biointerf., Vol. 32, pp. 125-135.
20. Paul, M., Fessi, H., Laatiris, A., Boulard, Y., Duram, R., Deniau, M. and Astier, A. (1997) 'Pentamidine-loaded poly(D,L-lactide) nanoparticles: physicochemical properties and stability work', Int. J. Pharm., Vol. 159, pp.223-232.
21. Leroueil-Le Verger, M., Fluckiger, L., Kim, Y., Hoffman, M. and Maincent, P. (1998) 'Preparation and characterization of nanoparticles containing an antihypertensive agent', Eur. J. Pharm. Biopharm., Vol. 46, pp.137-143.
22. Hu, Y., Jiang, X., Ding, Y., Ge, H., Yuan, Y. and Yang, C. (2002) 'Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles', Biomaterials, Vol. 23, pp.3193-3201.
23. Lopes, E., Pohlmann, A.R., Petrovick, P.R., Bassani, V. and Guterres, S.S. (2000) 'Polymeric colloidal systems containing ethionamide: preparation and physico-chemical characterization', Pharmazie, Vol. 55, No. 7, pp.527-530.
24. Cruz, L., Schaffazick, S.R., Dalla Costa, T., Soares, L.U., Mezzalira, G., Pesce da Silveira, N., Shapoval, E.S., Pohlmann, A.R. and Guterres, S.S. (2006) 'Physico-chemical characterization and in vivo evaluation of indomethacin ethyl ester-loaded nanocapsules by PCS, TEM, SAXS, interfacial alkaline hydrolysis and antiedematogenic activity', J. Nanosci. Nanotechnol., Vol. 6, pp.3154-3162.
25. Müller, CR., Schaffazick, S.R., Pohlmann, A.R., Dalla Costa, T., Pesce da Silveira, N., de Lucca Freitas, L. and Guterres, S.S. (2001) 'Spray-dried diclofenac-loaded poly(ε-caprolactone) nanocapsules and nanospheres. Preparation and physicochemical characterization', Pharmazie, Vol. 56, No. 11, pp.864-867.
26. Pohlmann, A.R., Weiss, V., Mertins, O., Pesce da Silveira, N. and Guterres, S.S. (2002) 'Spray-dried indomethacin-loaded polyester nanocapsules and nanospheres: development, stability evaluation and nanostructure models', Eur. J. Pharm. Sci., Vol. 16, pp.305-312.
27. Kalgutkar, A.S., Marnett, A.B., Crews, B.C. and Remmel, R.P. (2000) 'Ester and amide derivatives of the nonsteroidal anti-inflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors', J. Med. Chem., Vol. 43, pp.2860-2870.
28. Fessi, H., Puisieux, F., Devissaguet, J.P., Amoury, N. and Benita, S. (1989) 'Nanocapsules formation by interfacial polymer deposition following solvent displacement', Int. J. Pharm., Vol. 55, pp.rl-r4.
29. ICH - International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (1994) 'Harmonised tripartide guideline', Validation of Analytical Methods: (Definitions and Terminology), Topic Q2A.
30. The United States Pharmacopeia 25 ed. (2002) United States Pharmacopoeial Convention Inc., Rockville, MD.
31. Korsmeyer, R.W., Gurny, R., Doelker, E., Buri, P. and Peppas, N.A. (1983) 'Mechanisms of solute release from porous hydrophilic polymers', Int. J. Pharm., Vol. 15, pp.25-35.
32. Winter, C.A., Risley, E.A. and Nuss, G.W. (1962) 'Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs', Proc. Soc. Exp. Biol. Med., Vol. 111, pp.544-547.
33. Magenheim, B. and Benita, S. (1991) 'Nanoparticles characterization: a comprehensive physicochemical approach', STP Pharma. Sci., Vol. 4, pp.221-241.
34. Legrand, P., Barratt, G., Mosqueira, V., Fessi, H. and Devissaguet, J-Ph. (1999) 'Polymeric nanocapsules as drug delivery systems. A review', STPPharma Sci, Vol. 9, pp.414-418.
35. Burchard, W. and Richtering, W. (1989) 'Dynamic light scattering from polymer solutions', Prog. Colloid Polym. Sci, Vol. 80, pp.151-163.
36. Berne, B.J. and Pecora, R. (1976) Dynamic Light Scattering, John Wiley & Sons, Inc., New York.
37. Jeong, J.C, Lee, J. and Cho, K. (2003) 'Effects of crystalline microstructure on drug release behavior of poly(epsilon-caprolactone) microspheres', J. Controlled Release, Vol. 92, pp.249-258.
38. Pohlmann, A.R., Soares, L.U., Cruz, L., Pesce da Silveira, N. and Guterres, S.S. (2004) 'Alkaline hydrolysis as a tool to determine the association form of indomethacin in nanocapsules prepared with poly(epsilon-caprolactone)', Curr. Drug Delivery, Vol. 1, pp. 103-110.
39. O'Hagan, D.T. (1990) 'Intestinal translocation of particulates - implications for drug and antigen delivery', Adv. Drug Delivery. Rev., Vol. 5, pp.265-285.
40. Kreuter, J. (1991) 'Peroral administration of nanoparticles', Adv. Drug Delivery. Rev., Vol. 7, pp.71-86.
41. Florence, A.T. (1997) 'The oral absorption of micro and nanoparticulates: neither exceptional nor unusual', Pharm. Res., Vol. 14, No. 3, pp.259-266.